A Chinese medicine compound composition with the effect of preventing and treating radiation damage, and its preparation method and application

Through the combination of traditional Chinese medicine compound compositions, especially the ratio of roasted Astragalus, Codonopsis pilosula, Raw Rehmannia, Ophiopogon japonicus, Schisandra chinensis, Ganoderma lucidum, schisandra chinensis, Ganoderma lucidum, sangatum vera, and Buddha hand, it was prepared into a variety of dosage forms, which solved the symptoms of damage after radiation treatment and achieved significant results. Preventive and therapeutic effects, and ensure the safety of drugs and the possibility of industrial production.

CN116672406BActive Publication Date: 2024-11-26JIANGSU PROVINCIAL HOSPITAL OF TCM
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310667957.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-06-07
Publication Date
2024-11-26
Estimated Expiration
2043-06-07

AI Technical Summary

Technical Problem

After radiation treatment, normal tissues and internal organs around the target area are easily exposed to radiation, resulting in a variety of adverse reactions. The existing prevention and treatment drugs are limited in efficacy or have toxic side effects. Traditional Chinese medicine has good efficacy but lacks systematic formulas.

Method used

Using a Chinese medicine compound prescription composed of roasted Astragalus, Codonopsis pilosula, Raw Rehmannia, Ophiopogon japonicus, Schisandra chinensis, Ganoderma lucidum, sangatum vera, and Buddha's hand, the best ratio was screened through the traditional Chinese medicine syndrome differentiation theory and treatment theory, and it was prepared into a variety of dosage forms for preventing and treating radioactive damage, including Oral liquid, granules, capsules, etc., can replenish qi and produce fluid, clear heat and detoxify, regulate qi and promote blood circulation.

Benefits of technology

It significantly prevents and treats radioactive injuries. The results of clinical experiments show that this compound can effectively improve symptoms such as dry oropharyngeal, fatigue, chest tightness, shortness of breath, dry and dull stool after radiotherapy, and has no obvious toxic side effects. The reasonable process design can achieve large-scale industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116672406B_ABST
    Figure CN116672406B_ABST
Patent Text Reader

Abstract

The invention discloses a Chinese medicine compound composition with the effect of preventing and treating radiation damage, and a preparation method and application thereof. The Chinese medicine compound composition is made of 15-45 parts of roasted astragalus, 10-30 parts of codonopsis, 10-30 parts of radix rehmanniae, 10-30 parts of ophiopogon, 10-30 parts of schisandra, 10-30 parts of ganoderma lucidum, 10-30 parts of scutellaria baicalensis, and 6-18 parts of citron. The invention adopts the theory of syndrome differentiation and treatment to optimize the prescription, and all the medicines are used together to replenish qi, produce body fluid, clear away heat and nourish yin. Clinical experimental results show that the Chinese medicine compound composition provided by the invention has significant effects of preventing radiation damage and relieving dry mouth, fatigue, leukopenia, anemia and the like after radiotherapy, and is safe for clinical use.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a Chinese medicinal compound, in particular to a Chinese medicinal compound for preventing and treating radiation damage. The invention also discloses a preparation method and medical use thereof. Background Art

[0002] Radiotherapy is a common treatment for malignant tumors. With the development of computer and imaging technology, new technologies such as intensity modulated radiotherapy and three-dimensional conformal radiotherapy have been continuously applied in clinical practice, and we have entered the era of precision radiotherapy. However, normal tissues around the target area, bone marrow tissues or visceral organ functions are still inevitably exposed to a certain dose of radiation. There are many adverse reactions after radiotherapy, including radiation pneumonia, radiation enteritis, radiation oral mucositis, radiation dermatitis, etc., which seriously reduce the quality of life of patients. At present, the means and drugs for the prevention and treatment of radiation damage include: radiation protectors, glucocorticoids, cytokines and growth factors, etc. However, these means have limited efficacy or have certain toxic side effects. Traditional Chinese medicine has better efficacy and no adverse reactions, and has certain advantages in preventing and treating radiation damage.

[0003] In traditional medicine, radiation belongs to the evil of "fire (heat), poison, and dryness". The pathological properties are particularly prominent in the evil of heat and dryness. Fire and heat are yang evils, which are most likely to force the body fluid to leak out and consume yin fluid. At the same time, they can burn the blood and cause poor qi movement; dryness is dry and astringent, which can easily consume the body's body fluids. Radiotherapy may cause qi stagnation and blood stasis, and damage to blood vessels; long-term treatment will lead to consumption of qi and damage to body fluids, qi deficiency and blood weakness, and dryness of essence. Therefore, we believe that the pathogenesis of this disease is mainly due to the deficiency of vital energy, damage to body fluids and yin deficiency, mixed with heat and toxicity, qi stagnation and blood stasis, and overall it belongs to the category of evil prevailing and the decline of the body. Qi disorder may occur in all organs. For example, if the spleen and stomach are damaged, the healthy movement will be impaired, the clear yang will not rise, and the stomach will not be harmonious and descend, resulting in loss of appetite, nausea and vomiting; fire and heat damage the lungs, the yin fluid is deficient, and the lungs lose moisture, leading to dry throat, thirst, dry cough and little sputum; liver and kidney yin deficiency, water does not contain wood, liver yang rises, kidney essence is deficient, and qi and blood have no source, resulting in deficiency of positive qi or deficiency of both qi and blood, which makes it more vulnerable to attack by other pathogens, especially cancer toxins. Therefore, the treatment method should also focus on replenishing vital energy, replenishing qi and nourishing yin, clearing away heat and detoxifying, promoting blood circulation and removing blood stasis, etc., and adopt a combination of multiple methods to prevent radiotherapy damage. Summary of the invention

[0004] Purpose of the invention: The purpose of the present invention is to solve the deficiencies of the prior art and to provide a Chinese medicine compound with a scientific and reasonable ratio and significant effect in preventing and treating radiation damage; another purpose of the present invention is to provide a preparation method of the Chinese medicine compound composition and its application.

[0005] Technical solution: In order to achieve the above purpose, the technical solution adopted by the present invention is:

[0006] A Chinese medicinal compound composition with the function of preventing and treating radiation damage is prepared from the following raw materials in parts by weight: 15-45 parts of roasted astragalus, 10-30 parts of codonopsis pilosula, 10-30 parts of radix rehmanniae, 10-30 parts of ophiopogon japonicus, 10-30 parts of schisandra chinensis, 10-30 parts of ganoderma lucidum, 10-30 parts of sarmentosum and 6-18 parts of citron.

[0007] As a preferred embodiment, the above-mentioned Chinese herbal compound composition with the function of preventing and treating radiation damage is characterized in that it is made of the following raw materials in parts by weight: 15-30 parts of roasted astragalus, 10-20 parts of codonopsis pilosula, 10-20 parts of raw rehmannia, 10-20 parts of ophiopogon, 10-20 parts of schisandra chinensis, 10-20 parts of ganoderma lucidum, 10-20 parts of sarmentosa, and 6-12 parts of citron.

[0008] As a preferred embodiment, the above-mentioned Chinese herbal compound composition with the function of preventing and treating radiation damage is characterized in that it is made of the following raw materials in parts by weight: 15 parts of roasted Astragalus, 10 parts of Codonopsis pilosula, 10 parts of Rehmannia glutinosa, 10 parts of Ophiopogon japonicus, 10 parts of Schisandra chinensis, 10 parts of Ganoderma lucidum, 10 parts of Sarcandra sylvestris, and 6 parts of Citron.

[0009] The invention is based on the theory of TCM syndrome differentiation and treatment, and screens the formula through a large number of clinical experiments. The whole Chinese medicine compound is used for preventing and treating radiation damage belonging to qi and yin deficiency syndrome, with symptoms of dryness of the mouth and throat, fatigue, poor appetite, chest tightness and shortness of breath, restlessness and insomnia, dry stool, occasional dry cough, or even erosion of the lips and skin, and thin pulse.

[0010] In the compound: Astragalus is sweet, slightly warm in nature, and replenishes Qi and produces blood; it is the main ingredient.

[0011] Codonopsis pilosula is sweet and neutral in nature, and can replenish qi, promote fluid production and nourish blood; Ophiopogon japonicus is sweet, slightly bitter and slightly cold in nature, and can nourish the yin of the lungs and stomach; Schisandra chinensis is sour and sweet in taste, and warm in nature, and can replenish qi, promote fluid production, nourish the kidneys and calm the mind; Radix Rehmanniae is sweet, bitter and cold in nature, and can clear away heat and cool blood, and can replenish yin and promote fluid production; Ganoderma lucidum is sweet and neutral in nature, and can nourish the body and promote blood circulation and remove blood stasis; Radix Scutellariae is bitter, pungent and neutral in nature, and can clear away heat and detoxify; all of them are ministerial drugs;

[0012] Buddha's hand tastes pungent, bitter, and sour, and regulates qi without harming yin; it is an adjuvant drug;

[0013] The combination of these medicines can replenish qi and produce body fluid, clear away heat and nourish yin. This prescription has the effects of replenishing qi and nourishing yin, clearing away heat and detoxifying, regulating qi and activating blood circulation.

[0014] A medicine with the function of preventing and treating radiation damage, which is prepared into oral liquid, granules, capsules, pills, tablets, powder injection, dripping pills, soft capsules or injection liquid dosage forms by using the extract of the Chinese medicine compound composition of the invention and a pharmaceutically acceptable carrier.

[0015] When the extracts of the raw materials of the traditional Chinese medicine compound provided by the present invention are made into oral liquid, the extracts of the raw materials are dissolved in distilled water, filtered, and the pH value is adjusted to make the oral liquid.

[0016] When the extracts of the raw materials of the traditional Chinese medicine compound provided by the present invention are made into tablets, the raw materials are mixed with lactose or corn starch, and lubricant magnesium stearate is added when necessary, mixed evenly, granulated, and then compressed into tablets.

[0017] When the extract of the traditional Chinese medicine compound provided by the invention is made into capsules, the extracts of various raw materials and carrier lactose or corn starch are evenly mixed, granulated, and then filled into capsules to make capsules.

[0018] When the extracts of various raw materials of the traditional Chinese medicine compound provided by the invention are made into granules, the extracts of various raw materials and diluent lactose or corn starch are evenly mixed, granulated, and dried to make granules.

[0019] When the extracts of various raw materials of the traditional Chinese medicine compound provided by the invention are made into powder injection, the extracts of various raw materials are freeze-dried and sterilized to make the powder injection.

[0020] When the extracts of the raw materials of the traditional Chinese medicine compound provided by the present invention are made into injection, the extracts of the raw materials are taken, added into physiological saline to dissolve, and then activated carbon is added, stirred evenly, heated at 80°C for 30 minutes, filtered, the pH value is adjusted, filtered with a vertical fritted glass funnel or other filter until clear, filled, and sterilized at 100 to 115°C for 30 minutes to prepare the injection.

[0021] The method for preparing the drug having the function of preventing and treating radiation damage of the present invention comprises the following steps:

[0022] (1) Take roasted astragalus, codonopsis, radix rehmanniae, ophiopogon, schisandra, ganoderma lucidum, scutellaria baicalensis, and citron in proportions by weight, extract with water to obtain a water extract, concentrate to obtain an extract, and set aside;

[0023] (2) The extract of step (1) is prepared with a pharmaceutically acceptable carrier into a drug in the form of oral solution, granules, capsules, pills, tablets, powder injection, dripping pills, soft capsules or injection solution.

[0024] As a preferred embodiment, in the method for preparing the above-mentioned drug having the function of preventing and treating radiation damage, the extraction method in step (1) is decoction, immersion or reflux extraction, the amount of water added is 6 to 15 times the weight of the medicinal material, the number of extractions is 1 to 3 times, and the extraction time is 0.5h to 2h.

[0025] The invention discloses an application of the Chinese medicinal compound composition with the function of preventing and treating radiation damage in the preparation of medicine for preventing and treating radiation damage.

[0026] Beneficial effects: The advantages of the Chinese medicine compound composition for preventing and treating radiation damage provided by the present invention are:

[0027] According to the theory of syndrome differentiation and treatment in traditional Chinese medicine, the present invention optimizes the best composition of 8 medicinal flavors and the best weight ratio through a large number of clinical experiments. The combination of the medicines can replenish qi and nourish yin, clear away heat and detoxify, and regulate qi and activate blood circulation. The clinical experimental results show that the Chinese medicine compound composition provided by the present invention has significant effects of preventing and treating dryness of the oropharynx, fatigue and poor appetite, chest tightness and shortness of breath, dry stool, insomnia and the like after radiotherapy. In addition, the clinical medication is safe and has no obvious toxic and side effects.

[0028] The preparation method of the Chinese medicine compound composition provided by the present invention has a reasonable whole process design, and the active components of each Chinese medicinal material are extracted separately by optimized industry. The prepared Chinese medicinal extract has high active components and few impurities, and can realize industrial large-scale production. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 This is a graph showing the results of cell activity detection.

[0030] Figure 2 This is an electron microscopic observation of the pyroptosis morphology of IEC-6 cells after ionizing radiation.

[0031] Figure 3 This is the result of flow cytometry detection of IEC-6 cell pyroptosis level after ionizing radiation.

[0032] Figure 4 Figure 3. Activity of caspase-1 in IEC-6 cells after ionizing radiation.

[0033] Figure 5 LDH detected IEC-6 cell membrane rupture and cytotoxicity after ionizing radiation.

[0034] Figure 6 This is a graph showing the results of measuring reactive oxygen species in IEC-6 cells after ionizing radiation.

[0035] Figure 7 The results of ELISA detection of IEC-6 cell-related inflammatory cytokine content after ionizing radiation.

[0036] Figure 8 This is a graph showing the results of Western Blot detection of the expression of key proteins involved in cell pyroptosis. DETAILED DESCRIPTION

[0037] The present invention is further explained below in conjunction with specific examples. It should be understood that these examples are only used to illustrate the present invention and are not used to limit the scope of the present invention. After reading the present invention, various equivalent modifications of the present invention by those skilled in the art all fall within the scope defined by the claims attached to this application.

[0038] Example 1

[0039] 1. A Chinese medicinal compound composition having the function of preventing and treating radiation damage, which is prepared from the following raw materials in parts by weight: 15g of roasted Astragalus, 10g of Codonopsis, 10g of Rehmannia, 10g of Ophiopogon, 10g of Schisandra, 10g of Ganoderma Lucidum, 10g of Sarcandra, and 6g of Citron.

[0040] 2. The method for preparing the Chinese medicinal compound composition having the effect of preventing and treating radiation damage according to the present invention comprises the following steps:

[0041] (1) Take 15g of roasted Astragalus, 10g of Codonopsis, 10g of Radix Rehmanniae, 10g of Radix Ophiopogonis, 10g of Fructus Schisandrae Chinensis, 10g of Ganoderma Lucidum, 10g of Radix Sarcandrae, and 6g of Citron, add water and decoct for extraction twice (the amount of water added is 8 times and 6 times, respectively, and the extraction time is 1.5h and 1h, respectively), combine the two extracts, concentrate to obtain a Chinese medicine compound extract (extract), and set aside;

[0042] (2) The extract prepared in step (1) is mixed evenly with a carrier of lactose or corn starch, and dried to prepare granules.

[0043] (Batch number: 001).

[0044] Example 2

[0045] 1. A Chinese medicinal compound composition having the function of preventing and treating radiation damage, which is prepared from the following raw materials in parts by weight: 30g of roasted Astragalus, 20g of Codonopsis, 20g of Rehmannia, 20g of Ophiopogon, 20g of Schisandra, 20g of Ganoderma Lucidum, 20g of Sarcandra, and 12g of Citron.

[0046] 2. The method for preparing the Chinese medicinal compound composition having the effect of preventing and treating radiation damage according to the present invention comprises the following steps:

[0047] (1) Take 30g of Astragalus, 20g of Codonopsis, 20g of Radix Rehmanniae, 20g of Radix Ophiopogonis, 20g of Schisandrae Chinensis, 20g of Ganoderma Lucidum, 20g of Radix Sarcandrae, and 12g of Citron, add water and decoct for extraction 3 times (the amount of water added is 8 times, 6 times, and 6 times, respectively, and the extraction time is 2h, 1h, and 1h, respectively), combine the 3 extracts, concentrate to obtain a Chinese medicine compound extract (extract), and set aside;

[0048] (2) Take the extract from step (1) and prepare an oral solution. (Batch number: 002)

[0049] Example 3

[0050] 1. A Chinese medicinal compound composition having the function of preventing and treating radiation damage, which is prepared from the following raw materials in parts by weight: 45g of roasted Astragalus, 30g of Codonopsis, 30g of Rehmannia, 30g of Ophiopogon, 30g of Schisandra, 30g of Ganoderma Lucidum, 30g of Sarcandra, and 18g of Citron.

[0051] 2. The method for preparing the Chinese medicinal compound composition having the effect of preventing and treating radiation damage according to the present invention comprises the following steps:

[0052] (1) Take 45g of roasted Astragalus, 30g of Codonopsis, 30g of Radix Rehmanniae, 30g of Radix Ophiopogonis, 30g of Fructus Schisandrae Chinensis, 30g of Ganoderma Lucidum, 30g of Radix Sarcandrae, and 18g of Citron, add water and decoct for extraction twice (the amount of water added is 8 times and 6 times respectively, and the extraction time is 2h and 1h respectively), combine the two extracts, concentrate to obtain the Chinese medicine compound extract (extract), and set aside;

[0053] (2) The extract prepared in step (1) is mixed evenly with the carrier lactose or corn starch, granulated, and then filled into capsules to prepare capsules (batch number: 003).

[0054] Example 4

[0055] The dry extract from step (1) of Example 1 was freeze-dried, sterilized, and prepared into a powder injection. (Batch No.: 004)

[0056] Example 5 Drug efficacy study

[0057] 1 Materials and methods

[0058] 1.1 Experimental Materials and Reagents

[0059] Table 1 Experimental materials and reagents

[0060]

[0061]

[0062] 1.2 Experimental instruments and equipment

[0063] Table 2 Experimental instruments and equipment

[0064]

[0065] 2 Experimental methods

[0066] 2.1 Cell culture

[0067] Rat small intestinal crypt epithelial cells (IEC-6) were cultured in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum (FBS), 100 U / ml penicillin, 0.1 mg / ml streptomycin and 100 U / mg insulin. The cells were divided into 4 groups: a blank control group, a model group, a NLRP3 gene silencing group and a Chinese medicine compound serum group containing the Chinese medicine compound extract prepared in Example 1. The control group was not irradiated and cultured conventionally; the cells in the model group were inoculated in a 6-well cell culture plate at a cell density of 3.5×10^5 cells / well, the distance between the cells and the radiation source was 100 cm, the irradiation dose was 8 Gy, the radiation dose rate was 2 Gy / min, and the irradiation field was 18 cm×18 cm to establish a radiation IEC-6 cell injury model; the NLRP3 gene silencing group: transfected with NLRP3 siRNA to silence the NLRP3 gene, and then received radiation treatment; the Chinese medicine compound medicated serum group: replaced with 10% Chinese medicine compound medicated serum for 24 hours, and then received radiation treatment.

[0068] 2.2 Cell transfection

[0069] IEC-6 cells in the logarithmic growth phase were inoculated in a 24-well plate at a cell density of 4×10^5 per well, with 3 parallel wells in each group. Three siRNA target sequences (final concentration 150nM) designed based on the rat NLRP3 mRNA sequence published in the Ensembl database were transfected into the cells using Lipofectamine 2000. Fresh culture medium was replaced 4-6 hours after transfection, and cells were collected after 48 hours of continuous culture. Western blot was used to screen out the NLRP3 siRNA with the best silencing efficiency for future use. The siRNA sequences are as follows: siRNA-1 (sense strand 5'-GGAGGAAGAAGAAGAGAAATT-3'; antisense strand

[0070] 5'-UUUCUCUUCUUCUUCCUCCTT-3'); siRNA-2 (sense 5'-GAAAGAAGUUGCUGCCUAATT-3'; antisense 5'-UUAGGCAGCAACUUCUUUCTT-3'); siRNA-3 (sense 5'-CCAAGAAGCUGCAGAGGCATT-3'; antisense 5'-UGCCUCUGCAGCUUCUUGGTT-3'); NC (sense 5'-UUCUCCGAACGUGUCACGUTT-3'; antisense 5'-ACGUGACACGUUCGGAGAATT-3').

[0071] 2.3 MTT assay for cell viability

[0072] IEC-6 cells in the logarithmic growth phase were seeded in 96-well plates at a density of 5000 cells per well and cultured for 24 hours. After the corresponding intervention, irradiation was performed at a predetermined dose and cultured for 24 hours. 20 μL MTT (5 mg mL -1 ), incubate for another 4 h, discard the supernatant, add 150 μL DMSO to each well, shake at low speed for 10 min to fully dissolve the formazan crystals, and then use an enzyme reader to measure the OD value at a wavelength of 570 nm.

[0073] 2.4 Electron microscopy observation of morphological changes in IEC-6 cell pyroptosis after ionizing radiation

[0074] The cells were digested with 0.25% Trypsin for 5 minutes, digestion was terminated, and the cells were centrifuged at 1000 rpm for 3 minutes. The supernatant was removed after centrifugation, and 1 mL of 2.5% glutaraldehyde in phosphate buffer (PH7.0) was added for fixation for 3 hours. The cells were rinsed with 0.1 M phosphate buffer PB (PH7.4) for 3 times, each time for 15 minutes, and then dehydrated with gradient alcohol and 100% acetone, infiltrated with acetone: 812 embedding agent, embedded in a 60°C oven for polymerization for 48 hours, stained with uranium-lead double staining, and finally observed under a transmission electron microscope, and images were collected and analyzed.

[0075] 2.5 Flow cytometry to detect pyroptosis in IEC-6 cells after ionizing radiation

[0076] Wash the cells in the 6-well plate twice with PBS, add 1ml 0.05% trypsin without EDTA, and add PBS to stop digestion when the cells become round. Use a pipette to gently blow the cells to suspend the cells, centrifuge at 300g for 5min, and discard the supernatant. Add PBS to wash once, centrifuge at 300g for 5min, and keep the precipitate. Add 100μL 1×Binding Buffer and 5μL PI mixed solution to the cell precipitate and incubate at room temperature in the dark for 15-20min. After incubation, add an appropriate amount (300-800μL) of 1×Binding Buffer according to the amount of cells to the appropriate concentration and detect on a flow cytometer within 1hour: PI red fluorescence is detected through the PI channel (FL2).

[0077] 2.6 Detection of caspase-1 activity in IEC-6 cells after ionizing radiation by flow cytometry / laser confocal microscopy

[0078] Collect cells, count, centrifuge and discard supernatant; adjust cell density to 1×10^6 / mL with PBS; add to EP tube containing FLICA dye, incubate at 37℃ in dark for 60min, shake gently every 10-20min to resuspend cells for staining. After labeling, centrifuge and discard supernatant; resuspend in Apoptosis Wash Buffer (AWB), let stand for 3min; centrifuge and discard supernatant; repeat washing 3 times; resuspend in pre-cooled AWB and place on ice within 1hour for flow cytometry detection: use FITC channel (excitation light is 488nm) for detection. When using laser confocal microscopy, observe under the laser with excitation light of 490nm and emission light of 530nm on the confocal culture dish, and cells containing active Caspase-1 covalently bound to FLICA appear green.

[0079] 2.7 LDH detection of IEC-6 cell membrane rupture and cytotoxicity after ionizing radiation

[0080] IEC-6 cells in the logarithmic growth phase were inoculated in 6-well plates at a cell density of 3.5×10^5 per well and cultured for 24 hours. After the corresponding intervention, the cells were irradiated at a predetermined dose and cultured for 24 hours. The cell supernatant of the sample to be tested was taken and centrifuged at 4°C for 10 minutes. The standard was taken according to the instructions and diluted to different concentrations to make a standard curve. 10μL of the supernatant of the sample to be tested was taken. After that, 50μL of reagent 1 was added to the standard tube and the measurement tube, and 10μL of reagent 2 was added, mixed, reacted at 37°C for 15 minutes, and 50μL of reagent 3 was added. Mixed, reacted at 37°C for 15 minutes, reagent 4 was added, and room temperature was added for 3 minutes. Then 200μL was taken to a 96-well plate and detected at OD 450nm using a full-wavelength microplate reader.

[0081] 2.8 Determination of the effect of traditional Chinese medicine on the activity of reactive oxygen species in IEC-6 cells after ionizing radiation

[0082] The cell slide was spread in a 24-well plate, and an appropriate amount of PBS was added for washing to make the slide completely adhere to the bottom of the 24-well plate; IEC-6 cells in the logarithmic growth phase were taken to prepare a single cell suspension according to the cell passaging steps, and the cell density was counted and adjusted to 3×10^4 cells / well and inoculated in a 24-well plate, and cultured for 24 hours; after the corresponding intervention, irradiation was performed according to the predetermined dose, and then cultured for 24 hours. After the culture was completed, the mitochondrial probe was diluted with serum-free culture medium at a ratio of 1:2000; the original supernatant was discarded, and the cells were washed twice with PBS to avoid the influence of serum on the probe as much as possible; the configured probe was added, and the cells were placed in an incubator and incubated in the dark for 15-30 minutes; after the incubation was completed, the supernatant was discarded, and the cells were washed 3 times with PBS to remove the probe that did not enter the cells; the slides were sealed with serum-free culture medium, and photographed immediately under a fluorescence microscope.

[0083] 2.9ELISA detection: NF-κB, NLRP3 and GSDMD

[0084] The cell supernatant of each group was collected and assayed according to the instructions of the ELISA kit.

[0085] 2.10WB detection: NF-κB, NLRP3 and GSDMD protein expression levels in IEC-6 cells

[0086] (1) SDS-PAGE electrophoresis

[0087] Clean the glass plate. After the glass plate is dry, put a concave glass plate and a flat glass plate together as a pair, with the flat glass facing outward and the concave glass inside. There is a gap between the glass plates for glue filling. Put them into the glue maker and check whether the bottom is aligned to avoid glue leakage.

[0088] Prepare 10% separation gel according to the experimental requirements, and shake it immediately after adding TEMED to pour the gel. Pour the separation gel to an appropriate height. You can use a comb to test it before pouring the gel. The comb teeth should be about 5-8mm away from the liquid surface of the separation gel. Then slowly and evenly add anhydrous ethanol to the gap until it is full. Be careful not to disperse the gel during the process. After about 30 minutes, the separation gel solidifies, pour out the anhydrous ethanol, and use absorbent paper to absorb the remaining liquid.

[0089] Prepare 5% concentrated gel according to the instructions, add TEMED and shake well immediately to pour the gel. Fill the remaining space with concentrated gel, then insert the comb into the concentrated gel, making sure there are no bubbles under the comb. After the concentrated gel solidifies, remove the gel dispenser, carefully pull out the comb, and you are ready to start electrophoresis.

[0090] Place the gel caster in the electrophoresis tank, add enough electrophoresis solution, and add protein marker and sample in order. Run at 80V for 20 minutes, then run at 120V for 1 hour.

[0091] (2) Transfer

[0092] Place a transfer clamp, two sponge pads, and two thick filter papers in a plate with transfer solution. Open the gel plate, cut the gel according to the size of the target protein, and place it in the plate. Cut the PVDF (0.45um) according to the size of the gel, and activate the PVDF membrane in methanol. Open the clamp, the left side is white, the right side is black, and add a sponge and a layer of thick filter paper on each side. Carefully place the gel on the black filter paper, cover the PVDF membrane on the gel, and do not allow bubbles. Cover the membrane with a piece of filter paper, and finally cover it with another sponge pad.

[0093] Transfer conditions (wet transfer): Place the transfer tank in ice water for transfer, and transfer at a constant current of 200 mA for 70 minutes.

[0094] (3) Immune response

[0095] Place the transferred membrane in an incubation tank filled with TBST, rinse quickly once, then add an appropriate amount of blocking solution, place on a decolorizing shaker, and block at room temperature for 1 hour. Dilute the primary antibody according to the antibody instructions, and after preparation, pour out the blocking solution in the incubation tank, add the prepared primary antibody (blocking solution 1:1000 dilution), and incubate on a shaker at 4°C overnight (shake slowly).

[0096] The membrane was quickly rinsed three times with TBST, then TBST was added and the membrane was quickly eluted on a decolorizing shaker for 10 minutes each time, and washed three times. The secondary antibody was diluted with blocking solution at a ratio of 1:5000, then added to the incubation tank, slowly shaken on a shaker, and incubated at room temperature for 1 hour. The secondary antibody was poured out, and TBST was added again, and the membrane was quickly eluted on a decolorizing shaker for 10 minutes each time, and washed three times.

[0097] (4) Exposure

[0098] In a dark room, mix developer A and developer B in a ratio of 1:1, and develop one strip at a time, developing each strip in turn, and adjusting the exposure conditions according to different luminous intensities.

[0099] (5) Membrane washing

[0100] Wash the membrane according to the instructions of the membrane regeneration solution (strong), and then carry out sealing and other steps according to steps (3) and (4).

[0101] (6) Experimental reagent formula

[0102] Electrophoresis buffer: 3.03 g Tris + 14.4 g glycine + 1 g SDS, dilute to 1 L with dH2O.

[0103] Transfer buffer: 3.03g Tris + 14.4g glycine + 200mL methanol, dH2O to 1L.

[0104] Blocking solution: 5 g skim milk powder + 100 mL 0.1% TBST, mix thoroughly.

[0105] Table 3 SDS-PAGE separation gel formula

[0106]

[0107] Table 4 SDS-PAGE stacking gel formula

[0108]

[0109]

[0110] 2.11 Statistical analysis

[0111] Each experiment was repeated at least 3 times. The values ​​are expressed as mean ± standard error (Means ± SEM). For all experimental data, Graphpad prism8 software was used to organize the data between groups, and variance (ANOVA) statistical analysis was performed in SPSS 22.0 version (SPSS). The comparison of the mean significance difference between the two groups was performed using Student's t test, one-tailed test, and the significance level was set at α = 0.05 (compared with the control group, # indicates P < 0.05; ## indicates P < 0.01; compared with the model group, * indicates P < 0.05; ** indicates P < 0.01).

[0112] 3 Experimental Results

[0113] 3.1 Cell viability assay

[0114] like Figure 1 As shown, compared with the blank control group, the cell activity in the model group was significantly reduced (p<0.01); compared with the model group, silencing the NLRP3 gene and the Chinese herbal compound-containing serum significantly increased the cell activity (p<0.01).

[0115] 3.2 Electron microscopy observation of morphological changes in IEC-6 cell pyroptosis after ionizing radiation

[0116] like Figure 2 As shown, the cell membrane of IEC-6 cells in the blank control group was intact and the mitochondrial structure was clear; the IEC-6 cells in the model group showed cell swelling, cell membrane rupture, and unclear mitochondrial structure, which was consistent with the characteristics of cell pyroptosis; the integrity of the cell membrane was improved to a certain extent by silencing the NLRP3 gene and administering the Chinese herbal compound-containing serum, and the mitochondrial structure was clearer than that of the model group.

[0117] 3.3 Flow cytometry detection of IEC-6 cell pyroptosis after ionizing radiation

[0118] like Figure 3 As shown in the results, compared with the blank control group, the proportion of PI-positive cells in the model group was significantly increased (p<0.01); compared with the model group, silencing the NLRP3 gene and the serum containing the Chinese herbal compound significantly reduced the proportion of PI-positive cells (p<0.01).

[0119] 3.4 Caspase-1 activity in IEC-6 cells after ionizing radiation

[0120] like Figure 4As shown in the figure, compared with the blank control group, the activity of caspase-1 in IEC-6 cells in the model group was extremely significantly increased (p<0.01); compared with the model group, the proportion of caspase-1 positive cells in the NLRP3 gene silencing group and the Chinese medicine compound serum group was significantly decreased (p<0.05), and the fluorescence intensity of caspase-1 was extremely significantly decreased (p<0.01).

[0121] 3.5 LDH detection of IEC-6 cell membrane rupture and cytotoxicity after ionizing radiation

[0122] like Figure 5 As shown in the figure, compared with the blank control group, the LDH content released by IEC-6 cells in the model group was extremely significantly increased (p<0.01); compared with the model group, the LDH content released by IEC-6 cells in the NLRP3 gene silencing group and the Chinese medicine compound serum group was extremely significantly decreased (p<0.01).

[0123] 3.6 Determination of reactive oxygen species in IEC-6 cells after ionizing radiation

[0124] like Figure 6 As shown in the figure, compared with the blank control group, the level of reactive oxygen species in IEC-6 cells in the model group was extremely significantly increased (p<0.01); compared with the model group, silencing the NLRP3 gene and the serum containing the Chinese herbal compound extremely significantly reduced the level of reactive oxygen species in IEC-6 cells (p<0.01).

[0125] 3.7ELISA detection of inflammatory cytokine levels in IEC-6 cells after ionizing radiation

[0126] like Figure 7 As shown in the results, compared with the blank control group, the levels of NF-κB, NLRP3 and GSDMD in the culture supernatant of IEC-6 cells in the model group were significantly increased (p<0.01); compared with the model group, NLRP3 gene silencing and serum containing Chinese herbal compound significantly reduced the levels of inflammatory cytokines NF-κB, NLRP3 and GSDMD in the culture supernatant of IEC-6 cells (p<0.01).

[0127] 3.8 Western Blot detection of the expression of key proteins in cell pyroptosis

[0128] like Figure 8 As shown in the figure, compared with the blank control group, the phosphorylation levels of NLRP3 and NF-κB and the expression level of GSDMD N-terminal fragment in IEC-6 cells in the model group were significantly increased (p<0.01); compared with the model group, silencing the NLRP3 gene and the serum containing the Chinese herbal compound significantly reduced the phosphorylation levels of NLRP3 and NF-κB and the expression level of GSDMD N-terminal fragment in IEC-6 cells (p<0.01).

[0129] Example 6 Clinical Study

[0130] 1. Clinical study: Through retrospective analysis, the effect and safety of the Chinese medicine compound composition of the present invention in preventing and treating radiation damage are evaluated.

[0131] 1. Inclusion criteria: ① The histopathological examination meets the diagnostic criteria of the "Chinese Common Malignant Tumor Diagnosis and Treatment Guidelines" compiled by the Medical Administration Department of the Ministry of Health of the People's Republic of China; ② Receive conventional radiotherapy; ③ The disease-free survival time can be clearly assessed; ④ No history of other malignant tumors and no other serious diseases that conflict with the study; ⑤ Can be followed up.

[0132] 2. Research subjects: Before the start of the trial, a random number table was simulated using SAS software to screen and enroll subjects who met the requirements of the study plan and divide them into an observation group and a control group, with 30 cases in each group. There was no significant difference in the general data of the two groups of patients before treatment (P>0.05), and they were comparable.

[0133] 3. Grouping: All cases were randomly divided into two groups: Group A was the test group of "the Chinese medicine compound extract prepared in Example 1", 30 cases; Group B was the control group, 30 cases. The control group did not take Chinese medicine.

[0134] 4. Observation indicators: Main endpoint indicators: The main outcome indicators are the incidence of radiation damage (including radiation skin damage, radiation oral mucositis, radiation pneumonia, radiation enteritis, etc.). Secondary endpoint indicators: The secondary endpoint indicators are quality of life. The quality of life of patients was evaluated according to the patient assessment of constipation-quality of life (PAC-QOL), which includes four dimensions: physiological, psychological, worry, and satisfaction, with a total of 28 questions, each question is scored 1 to 5 points, a total of 140 points, the higher the score, the worse the quality of life.

[0135] 5. Efficacy observation and data statistics: Through control, comparison and statistical processing, the clinical efficacy and safety of the Chinese medicine compound in preventing and treating radiation injury are studied.

[0136] 6. Results:

[0137] 6.1 Comparison of the incidence of radiation injury prevention

[0138] The incidence of radiation damage in the experimental group of the Chinese medicine composition of Example 1 of the present invention was 10%; the incidence in the control group was 23.3%. 2 Test, P < 0.05, there is a significant difference, as shown in Table 5.

[0139] Table 5: Comparison of the incidence of radiation injury between the two groups of patients (%)

[0140]

[0141] *P<0.05, compared with the control group 6.2 Comparison of TCM symptom scores before and after radiotherapy

[0142] There were statistically significant differences in dry mouth (P<0.01), fatigue (P<0.05), constipation (P<0.05), nausea (P<0.05), insomnia (P<0.01) and total score (P<0.01) between the experimental group and the control group (see Table 6). There were also significant differences in the experimental group before and after radiotherapy (P<0.01).

[0143] Table 6 Comparison of TCM symptom scores between the treatment group and the control group before and after radiotherapy

[0144]

[0145]

[0146] Note: Compared with the group before treatment, *P<0.05, **P<0.01; compared with the control group, △P<0.05, △△P<0.016.3 Comparison of quality of life before and after radiotherapy

[0147] After treatment, there was a statistically significant difference in the quality of life scores between the two groups (P < 0.05); at the same time, there was also a significant difference in the experimental group's own control before and after treatment (P < 0.05) (see Table 7).

[0148] Table 7 Comparison of quality of life scores between the two groups before and after treatment

[0149]

[0150] Note: Compared with the group before treatment, *P<0.05; compared with the control group, △P<0.05

[0151] According to the theory of traditional Chinese medicine and the clinical manifestations of radiation injury, the present invention summarizes the symptoms into deficiency of both qi and yin, and excessive heat and damage to body fluid. The treatment is treated by invigorating qi and generating body fluid, clearing away heat and nourishing yin. Through a large number of experimental screenings, the preferred Chinese medicine compound of the present invention is: astragalus, codonopsis, radix rehmanniae, ophiopogon, schisandra, ganoderma lucidum, scutellaria baicalensis, and citron. Astragalus is sweet in nature and slightly warm in taste, invigorates qi and generates blood; it is the main drug. Codonopsis pilosula is sweet and neutral in nature, replenishes qi, promotes fluid production and nourishes blood; Ophiopogon japonicus is sweet, slightly bitter and slightly cold in nature, nourishes the yin of the lungs and stomach; Schisandra chinensis is sour and sweet in nature, warm in nature, replenishes qi and promotes fluid production, nourishes the kidneys and calms the mind; Radix Rehmanniae is sweet, bitter and cold in nature, clears away heat and cools blood, replenishes yin and promotes fluid production; Ganoderma lucidum is sweet and neutral in nature, nourishes the root, promotes blood circulation and removes blood stasis; Radix Scutellariae is bitter, pungent and neutral in nature, clears heat and detoxifies; they are all ministerial drugs; Citron is pungent, bitter and sour in nature, regulates qi without hurting yin; they are adjuvant drugs; the eight drugs are used together to replenish qi and nourish yin, clear away heat and detoxify, regulate qi and promote blood circulation, and calm the mind. They have a very good preventive and therapeutic effect on radiation damage.

[0152] The present invention is based on the theory of traditional Chinese medicine and adopts the theory of syndrome differentiation and treatment to formulate the prescription. The above experimental results show that the Chinese medicine compound provided by the present invention has the effect of preventing and treating radiation damage, and no adverse reactions are found in the long-term use of this Chinese medicine compound in clinical applications, and the medication is safe.

[0153] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A Chinese medicinal compound composition having the effect of preventing and treating radiation damage, characterized in that: The invention is prepared from the following raw materials in parts by weight: 15-45 parts of roasted astragalus, 10-30 parts of codonopsis pilosula, 10-30 parts of radix rehmanniae, 10-30 parts of ophiopogon japonicus, 10-30 parts of schisandra chinensis, 10-30 parts of ganoderma lucidum, 10-30 parts of scutellaria baicalensis and 6-18 parts of citron.

2. The Chinese medicinal compound composition having the effect of preventing and treating radiation damage according to claim 1, characterized in that: The invention is prepared from the following raw materials in parts by weight: 15-30 parts of roasted astragalus, 10-20 parts of codonopsis pilosula, 10-20 parts of radix rehmanniae, 10-20 parts of ophiopogon japonicus, 10-20 parts of schisandra chinensis, 10-20 parts of ganoderma lucidum, 10-20 parts of scutellaria baicalensis and 6-12 parts of citron.

3. The Chinese medicinal compound composition having the effect of preventing and treating radiation damage according to claim 2, characterized in that: The invention is prepared from the following raw materials in parts by weight: 15 parts of roasted astragalus, 10 parts of codonopsis pilosula, 10 parts of radix rehmanniae, 10 parts of ophiopogon japonicus, 10 parts of schisandra chinensis, 10 parts of ganoderma lucidum, 10 parts of scutellaria baicalensis and 6 parts of citron.

4. A drug having the effect of preventing and treating radiation damage, characterized in that: The extract of the Chinese medicine compound composition according to any one of claims 1 to 3 and a pharmaceutically acceptable carrier are prepared into a medicine in the form of oral liquid, granules, capsules, pills or tablets.

5. The method for preparing the drug having the function of preventing and treating radiation damage according to claim 4, characterized in that: The following steps are involved: (1) Take the roasted Astragalus, Codonopsis, Radix Rehmanniae, Radix Ophiopogonis, Fructus Schisandrae Chinensis, Ganoderma Lucidum, Radix Sarcandrae, and Citron in the weight proportions as described in any one of claims 1 to 3, add water to extract, obtain a water extract, concentrate to obtain an extract, and set aside; (2) The extract of step (1) is prepared into a drug in the form of oral liquid, granules, capsules, pills or tablets by mixing with a pharmaceutically acceptable carrier.

6. The method for preparing the drug for preventing and treating radiation damage according to claim 5, characterized in that: The extraction method in step (1) is decoction, maceration or reflux extraction, the amount of water added is 6 to 15 times the weight of the medicinal material, the number of extractions is 1 to 3 times, and the extraction time is 0.5 h to 2 h.

7. Use of the Chinese medicine compound composition according to any one of claims 1 to 3 in the preparation of drugs for treating radiation damage.